INGN - NASDAQ

Inogen, Inc.

INGN·NASDAQ

$5.98

-1.6%

HealthcareMedical - Devices

Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Inogen Tidal Assist Ventilators, as well as related accessories. The company also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$161.91M

EPS-0.8500

P/E Ratio-7.04

Earnings Date08/06/2026

ingn

Selling, General and Administrative Expenses

Last Annual Value

165.07M

3-Year CAGR

5-Year CAGR

10-Year CAGR

11%

Adjust for Inflation

Inogen, Inc. Competitors Analysis of Selling, General and Administrative Expenses

INGN · NASDAQ

Company	Selling, General and Administrative Expenses	CAGR 3Y	CAGR 5Y	CAGR 10Y
Inogen, Inc. NASDAQ:INGN	165.07M	-3.3%	1.8%	9.1%
Perspective Therapeutics, Inc. AMEX:CATX	30.23M	12.8%	26.3%	17.1%
CVRx, Inc. NASDAQ:CVRX	88.47M	11.1%	26.0%	N/A
OraSure Technologies, Inc. NASDAQ:OSUR	73.79M	-7.1%	-4.9%	2.4%
SELLAS Life Sciences Group, Inc. NASDAQ:SLS	12.25M	-4.0%	1.6%	0.2%
Electromed, Inc. AMEX:ELMD	39.31M	7.6%	11.9%	10.6%
Shoulder Innovations, Inc. NYSE:SI	54.77M	33.3%	N/A	N/A
Quanterix Corporation NASDAQ:QTRX	138.01M	14.1%	8.2%	27.2%
Health Catalyst, Inc. NASDAQ:HCAT	102.04M	-10.8%	-8.7%	N/A
Outset Medical, Inc. NASDAQ:OM	92.22M	-13.3%	-1.9%	N/A
SANUWAVE Health, Inc. NASDAQ:SNWV	26.79M	25.4%	5.7%	25.9%

Inogen, Inc. Fair Value Envelope

INGN · NASDAQ

Our analysis suggests that INGN has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $5.98, this represents a potential HIDDEN relative to our calculated worth for Inogen, Inc..

HIDDEN

Intrinsic Value

Current Price: $5.98

Related Guides

Blog Categories

Continue your INGN research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.